{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:45:08Z","timestamp":1795031108445,"version":"4.10.2"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-026-02295-1","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T16:44:35Z","timestamp":1771346675000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diagnosis challenges and accessibility barriers to migraine management in Southeast Asia: results from the South-East Asia Local breAch on MigraiNe Treatment (SEALANT) study"],"prefix":"10.1186","volume":"27","author":[{"given":"Wanakorn","family":"Rattanawong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akarin","family":"Hiransuthikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakit","family":"Anukoolwittaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanakit","family":"Pongpitakmetha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sekh","family":"Thanprasertsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nijanth","family":"Manohararaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Aliaa Wan","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Saranza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Luis","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Dayrit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma Savitri","family":"Madjid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devi Ariani","family":"Sudibyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pepi","family":"Budianto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jr-Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Appasone","family":"Phoumindr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chananchida","family":"Sirilertmekasakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surat","family":"Tanprawate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart J.","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"1","key":"2295_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s10194-020-01208-0","volume":"21","author":"TJ Steiner","year":"2020","unstructured":"Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z (2020) Migraine remains second among the world\u2019s causes of disability, and first among young women: findings from GBD2019. J Headache Pain 21(1):137","journal-title":"J Headache Pain"},{"issue":"10440","key":"2295_CR2","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"Global incidence","year":"2024","unstructured":"Global incidence (2024) prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet 403(10440):2133\u20132161","journal-title":"Lancet"},{"issue":"4","key":"2295_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/01632787241285993","volume":"48","author":"J Batchelor","year":"2025","unstructured":"Batchelor J, Hemmert C, Meulenbroeks I, Tang C, Harrison R, Ogrin R et al (2025) Factors influencing the translation of evidence into clinical practice for hospital allied health professionals in terms of the domains of behaviour change theory: A systematic review. Eval Health Prof 48(4):471\u2013489","journal-title":"Eval Health Prof"},{"issue":"1","key":"2295_CR4","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1186\/s40001-023-01555-z","volume":"28","author":"M Jokubaitis","year":"2023","unstructured":"Jokubaitis M, Vrublevska G, Zvaune L, Braschinsky M, Leheste AR, Sakn\u012btis G et al (2023) Accuracy of migraine diagnosis and treatment by neurologists in the Baltic states: e-survey with clinical case challenge. Eur J Med Res 28(1):600","journal-title":"Eur J Med Res"},{"issue":"3","key":"2295_CR5","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/ene.14098","volume":"27","author":"M Viana","year":"2020","unstructured":"Viana M, Khaliq F, Zecca C, Figuerola MDL, Sances G, Di Piero V et al (2020) Poor patient awareness and frequent misdiagnosis of migraine: findings from a large transcontinental cohort. Eur J Neurol 27(3):536\u2013541","journal-title":"Eur J Neurol"},{"issue":"2","key":"2295_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1526-4610.2010.01778.x","volume":"51","author":"G Viticchi","year":"2011","unstructured":"Viticchi G, Silvestrini M, Falsetti L, Lanciotti C, Cerqua R, Luzzi S et al (2011) Time delay from onset to diagnosis of migraine. Headache 51(2):232\u2013236","journal-title":"Headache"},{"issue":"5","key":"2295_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/head.12774","volume":"56","author":"DW Dodick","year":"2016","unstructured":"Dodick DW, Loder EW, Manack Adams A, Buse DC, Fanning KM, Reed ML et al (2016) Assessing barriers to chronic migraine Consultation, Diagnosis, and treatment: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache 56(5):821\u2013834","journal-title":"Headache"},{"issue":"8","key":"2295_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1212\/01.wnl.0000323925.29520.e7","volume":"71","author":"ME Bigal","year":"2008","unstructured":"Bigal ME, Serrano D, Reed M, Lipton RB (2008) Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 71(8):559\u2013566","journal-title":"Neurology"},{"issue":"4","key":"2295_CR9","doi-asserted-by":"publisher","first-page":"333102424124565","DOI":"10.1177\/03331024241245658","volume":"44","author":"W Rattanawong","year":"2024","unstructured":"Rattanawong W, Rapoport A, Srikiatkhachorn A (2024) Medication underuse headache. Cephalalgia 44(4):3331024241245658","journal-title":"Cephalalgia"},{"issue":"1","key":"2295_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s10194-022-01431-x","volume":"23","author":"S Sacco","year":"2022","unstructured":"Sacco S, Amin FM, Ashina M, Bendtsen L, Deligianni CI, Gil-Gouveia R et al (2022) European headache federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention\u2009\u2013\u20092022 update. J Headache Pain 23(1):67","journal-title":"J Headache Pain"},{"issue":"4","key":"2295_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/head.14692","volume":"64","author":"AC Charles","year":"2024","unstructured":"Charles AC, Digre KB, Goadsby PJ, Robbins MS, Hershey A (2024) Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: an American headache society position statement update. Headache 64(4):333\u2013341","journal-title":"Headache"},{"issue":"4","key":"2295_CR12","doi-asserted-by":"publisher","first-page":"333102425132150","DOI":"10.1177\/03331024251321500","volume":"45","author":"R Ornello","year":"2025","unstructured":"Ornello R, Caponnetto V, Ahmed F, Al-Khazali HM, Ambrosini A, Ashina S et al (2025) Evidence-based guidelines for the Pharmacological treatment of migraine, summary version. Cephalalgia 45(4):3331024251321500","journal-title":"Cephalalgia"},{"issue":"2","key":"2295_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/head.14259","volume":"62","author":"RB Lipton","year":"2022","unstructured":"Lipton RB, Nicholson RA, Reed ML, Araujo AB, Jaffe DH, Faries DE et al (2022) Diagnosis, consultation, treatment, and impact of migraine in the US: results of the OVERCOME (US) study. Headache 62(2):122\u2013140","journal-title":"Headache"},{"issue":"1","key":"2295_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s10194-023-01623-z","volume":"24","author":"J Pascual","year":"2023","unstructured":"Pascual J, Panni T, Dell\u2019Agnello G, Gonderten S, Novick D, Evers S (2023) Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) study. J Headache Pain 24(1):88","journal-title":"J Headache Pain"},{"key":"2295_CR15","doi-asserted-by":"publisher","first-page":"1222912","DOI":"10.3389\/fneur.2023.1222912","volume":"14","author":"YF Wang","year":"2023","unstructured":"Wang YF, Wang SJ, Huang YH, Chen YT, Yen YC, Shia BC et al (2023) Treatment pattern and health care resource utilization for Taiwanese patients with migraine: a population-based study. Front Neurol 14:1222912","journal-title":"Front Neurol"},{"issue":"5","key":"2295_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s40263-021-00818-9","volume":"35","author":"C Sun-Edelstein","year":"2021","unstructured":"Sun-Edelstein C, Rapoport AM, Rattanawong W, Srikiatkhachorn A (2021) The evolution of medication overuse headache: History, pathophysiology and clinical update. CNS Drugs 35(5):545\u2013565","journal-title":"CNS Drugs"},{"issue":"1","key":"2295_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s10194-025-02046-8","volume":"26","author":"R Ishii","year":"2025","unstructured":"Ishii R, Takizawa T, Suzuki S, Danno D, Miura M, Tanizawa Y et al (2025) Real-world use of over-the-counter medications by patients with migraine in japan: results from the OVERCOME (Japan) 2nd study. J Headache Pain 26(1):107","journal-title":"J Headache Pain"},{"key":"2295_CR18","unstructured":"Organization WH, Thailand (2024) Population Data: World Health Organization; [updated 2025-02-01. Available from: https:\/\/data.who.int\/countries\/764"},{"key":"2295_CR19","unstructured":"Bank W, Thailand (2024) GDP per capita (current US$): World Bank Group; [updated 2025-02-01. Available from: https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD?locations=TH"},{"key":"2295_CR20","unstructured":"Neuronetworks.org Number of Neurologists in Thailand: Neuronetworks; 2024 [updated 2025-02-01. Available from: https:\/\/neuronetworks.org\/?p=2708"},{"key":"2295_CR21","unstructured":"Organization WH, Malaysia (2024) Population Data: World Health Organization; [updated 2025-02-01. Available from: https:\/\/data.who.int\/countries\/458"},{"key":"2295_CR22","unstructured":"Bank W, Malaysia (2024) GDP per capita (current US$): World Bank Group; [updated 2025-02-01. Available from: https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD?locations=MY"},{"issue":"7","key":"2295_CR23","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00702-023-02662-1","volume":"130","author":"R Bhidayasiri","year":"2023","unstructured":"Bhidayasiri R, Sringean J, Van Le T, Lim TT, Navuth C, Phoumindr A et al (2023) Movement disorders in indochina: resource challenges and future solutions. J Neural Transm (Vienna) 130(7):875\u2013889","journal-title":"J Neural Transm (Vienna)"},{"key":"2295_CR24","unstructured":"Organization WH, Singapore (2024) Population Data: World Health Organization; [updated 2025-02-01. Available from: https:\/\/data.who.int\/countries\/702"},{"key":"2295_CR25","unstructured":"Bank W, Singapore (2024) GDP per capita (current US$): World Bank Group; [updated 2025-02-01. Available from: https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD?locations=SG"},{"issue":"1","key":"2295_CR26","doi-asserted-by":"publisher","first-page":"e200201","DOI":"10.1212\/NE9.0000000000200201","volume":"4","author":"SL Fong","year":"2025","unstructured":"Fong SL, Lim KS, Lim SH, Octaviana F, Tran TC, Thuy Le MA et al (2025) Education research: training of neurologists in South East Asian countries: A Cross-Sectional survey on the current neurology curriculum. Neurol Educ 4(1):e200201","journal-title":"Neurol Educ"},{"key":"2295_CR27","unstructured":"Organization WH, Taiwan (2024) Population Data: World Health Organization; [updated 2025-02-01. Available from: https:\/\/data.who.int\/countries\/TWN"},{"key":"2295_CR28","unstructured":"Bank W, Taiwan (2024) GDP per capita (current US$): World Bank Group; [updated 2025-02-01. Available from: https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD?locations=TW"},{"key":"2295_CR29","unstructured":"Organization WH, Philippines (2024) Population Data: World Health Organization; [updated 2025-02-01. Available from: https:\/\/data.who.int\/countries\/608"},{"key":"2295_CR30","unstructured":"Bank W, Philippines (2024) GDP per capita (current US$): World Bank Group; [updated 2025-02-01. Available from: https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD?locations=PH"},{"key":"2295_CR31","unstructured":"Organization WH, Indonesia (2024) Population Data: World Health Organization; [updated 2025-02-01. Available from: https:\/\/data.who.int\/countries\/360"},{"key":"2295_CR32","unstructured":"Bank W, Indonesia (2024) GDP per Capita (current US$): World Bank Group; [updated 2025-02-01. Available from: https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD?locations=ID"},{"key":"2295_CR33","unstructured":"Organization WH, Laos (2024) Population Data: World Health Organization; [updated 2025-02-01. Available from: https:\/\/data.who.int\/countries\/418"},{"key":"2295_CR34","unstructured":"Bank W, Laos (2024) GDP per capita (current US$): World Bank Group; [updated 2025-02-01. Available from: https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD?locations=LA"},{"key":"2295_CR35","doi-asserted-by":"publisher","first-page":"100094","DOI":"10.1016\/j.ynpai.2022.100094","volume":"12","author":"W Rattanawong","year":"2022","unstructured":"Rattanawong W, Rapoport A, Srikiatkhachorn A (2022) Neurobiology of migraine progression. Neurobiol Pain 12:100094","journal-title":"Neurobiol Pain"},{"issue":"1","key":"2295_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s10194-018-0839-1","volume":"19","author":"Z Katsarava","year":"2018","unstructured":"Katsarava Z, Mania M, Lampl C, Herberhold J, Steiner TJ (2018) Poor medical care for people with migraine in Europe - evidence from the Eurolight study. J Headache Pain 19(1):10","journal-title":"J Headache Pain"},{"key":"2295_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s10194-016-0613-1","volume":"17","author":"M Braschinsky","year":"2016","unstructured":"Braschinsky M, Haldre S, Kals M, Iofik A, Kivisild A, Korjas J et al (2016) Structured education can improve primary-care management of headache: the first empirical evidence, from a controlled interventional study. J Headache Pain 17:24","journal-title":"J Headache Pain"},{"key":"2295_CR38","doi-asserted-by":"publisher","first-page":"100427","DOI":"10.1016\/j.ensci.2022.100427","volume":"29","author":"D Mortel","year":"2022","unstructured":"Mortel D, Kawatu N, Steiner TJ, Saylor D (2022) Barriers to headache care in low- and middle-income countries. eNeurologicalSci 29:100427","journal-title":"eNeurologicalSci"},{"issue":"10283","key":"2295_CR39","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(20)32160-7","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Katsarava Z, Do TP, Buse DC, Pozo-Rosich P, \u00d6zge A et al (2021) Migraine: epidemiology and systems of care. Lancet 397(10283):1485\u20131495","journal-title":"Lancet"},{"issue":"2","key":"2295_CR40","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s40120-020-00205-4","volume":"9","author":"S Wongsiriroj","year":"2020","unstructured":"Wongsiriroj S, Grillo E, Levi S, Zielman R, Lahouiri E, Marchina M et al (2020) Management of migraine and the accessibility of specialist care: findings from an extended multinational survey (My migraine center survey). Neurol Ther 9(2):551\u2013565","journal-title":"Neurol Ther"},{"issue":"9763","key":"2295_CR41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0140-6736(10)61507-3","volume":"377","author":"V Chongsuvivatwong","year":"2011","unstructured":"Chongsuvivatwong V, Phua KH, Yap MT, Pocock NS, Hashim JH, Chhem R et al (2011) Health and health-care systems in Southeast asia: diversity and transitions. Lancet 377(9763):429\u2013437","journal-title":"Lancet"},{"issue":"1","key":"2295_CR42","first-page":"1","volume":"16","author":"I Tonboot","year":"2023","unstructured":"Tonboot I, Wattanadumrong B, Pannarunothai S (2023) Distribution of Doctors and outpatient service workload by Thai elderly at the provincial Level, 2021. J Community Dev Res (Humanities Social Sciences) 16(1):1\u201312","journal-title":"J Community Dev Res (Humanities Social Sciences)"},{"issue":"4","key":"2295_CR43","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10194-011-0320-x","volume":"12","author":"TJ Steiner","year":"2011","unstructured":"Steiner TJ, Antonaci F, Jensen R, Lainez MJ, Lanteri-Minet M, Valade D (2011) Recommendations for headache service organisation and delivery in Europe. J Headache Pain 12(4):419\u2013426","journal-title":"J Headache Pain"},{"issue":"7","key":"2295_CR44","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.nrl.2018.12.006","volume":"37","author":"AB Gago-Veiga","year":"2022","unstructured":"Gago-Veiga AB, Cami\u00f1a Mu\u00f1iz J, Garc\u00eda-Azor\u00edn D, Gonz\u00e1lez-Quintanilla V, Ord\u00e1s CM, Torres-Ferrus M et al (2022) Headache: what to ask, how to examine, and which scales to use. Recommendations of the Spanish society of neurology\u2019s headache study group. Neurologia (Engl Ed) 37(7):564\u2013574","journal-title":"Neurologia (Engl Ed)"},{"issue":"8","key":"2295_CR45","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s11606-008-0591-3","volume":"23","author":"RB Lipton","year":"2008","unstructured":"Lipton RB, Hahn SR, Cady RK, Brandes JL, Simons SE, Bain PA et al (2008) In-office discussions of migraine: results from the American migraine communication study. J Gen Intern Med 23(8):1145\u20131151","journal-title":"J Gen Intern Med"},{"issue":"6","key":"2295_CR46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11916-015-0498-8","volume":"19","author":"EK Seng","year":"2015","unstructured":"Seng EK, Rains JA, Nicholson RA, Lipton RB (2015) Improving medication adherence in migraine treatment. Curr Pain Headache Rep 19(6):24","journal-title":"Curr Pain Headache Rep"},{"issue":"8","key":"2295_CR47","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-021-00509-5","volume":"17","author":"AK Eigenbrodt","year":"2021","unstructured":"Eigenbrodt AK, Ashina H, Khan S, Diener HC, Mitsikostas DD, Sinclair AJ et al (2021) Diagnosis and management of migraine in ten steps. Nat Rev Neurol 17(8):501\u2013514","journal-title":"Nat Rev Neurol"},{"issue":"13","key":"2295_CR48","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1177\/03331024211024153","volume":"41","author":"A Roxas Jr","year":"2021","unstructured":"Roxas A Jr., Quiles LE, Wang SJ (2021) Delivery of care for migraine in the Asian Oceanian region: A cross-sectional study. Cephalalgia 41(13):1348\u20131358","journal-title":"Cephalalgia"},{"issue":"7","key":"2295_CR49","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1212\/WNL.0000000000001256","volume":"84","author":"RB Lipton","year":"2015","unstructured":"Lipton RB, Fanning KM, Serrano D, Reed ML, Cady R, Buse DC (2015) Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology 84(7):688\u2013695","journal-title":"Neurology"},{"issue":"7","key":"2295_CR50","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/ene.14268","volume":"27","author":"HC Diener","year":"2020","unstructured":"Diener HC, Antonaci F, Braschinsky M, Evers S, Jensen R, Lainez M et al (2020) European academy of neurology guideline on the management of medication-overuse headache. Eur J Neurol 27(7):1102\u20131116","journal-title":"Eur J Neurol"},{"issue":"23","key":"2295_CR51","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1001\/jama.2021.7939","volume":"325","author":"JH VanderPluym","year":"2021","unstructured":"VanderPluym JH, Halker Singh RB, Urtecho M, Morrow AS, Nayfeh T, Torres Roldan VD et al (2021) Acute treatments for episodic migraine in adults: A systematic review and Meta-analysis. JAMA 325(23):2357\u20132369","journal-title":"JAMA"},{"key":"2295_CR52","doi-asserted-by":"publisher","first-page":"251581632412669","DOI":"10.1177\/25158163241266948","volume":"7","author":"P Anukoolwittaya","year":"2024","unstructured":"Anukoolwittaya P, Pongpitakmetha T, Hiransuthikul A, Thanprasertsuk S, Rattanawong W (2024) Awareness, knowledge, and practice towards medication overuse headache in thailand: A university hospital-based survey in residency training programs. Cephalalgia Rep 7:25158163241266948","journal-title":"Cephalalgia Rep"},{"issue":"1","key":"2295_CR53","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s10194-025-02160-7","volume":"26","author":"S Roongrojwittayakul","year":"2025","unstructured":"Roongrojwittayakul S, Anukoolwittaya P, Hiransuthikul A, Pongpitakmetha T, Thanprasertsuk S, Rattanawong W (2025) CGRP-targeted therapy fulfilling the treatment gap in medication-underuse setting: a retrospective cohort study at a tertiary headache center in Thailand, a lower-middle-income country. J Headache Pain 26(1):224","journal-title":"J Headache Pain"},{"issue":"6","key":"2295_CR54","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1177\/0333102414547138","volume":"35","author":"Z Hepp","year":"2015","unstructured":"Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB (2015) Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia 35(6):478\u2013488","journal-title":"Cephalalgia"},{"issue":"13","key":"2295_CR55","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1177\/03331024211024153","volume":"41","author":"A Roxas","year":"2021","unstructured":"Roxas A, Quiles LE, Wang S-J (2021) Delivery of care for migraine in the Asian Oceanian region: A cross-sectional study. Cephalalgia 41(13):1348\u20131358","journal-title":"Cephalalgia"},{"issue":"1","key":"2295_CR56","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s10194-024-01859-3","volume":"25","author":"P Anukoolwittaya","year":"2024","unstructured":"Anukoolwittaya P, Hiransuthikul A, Pongpitakmetha T, Thanprasertsuk S, Rattanawong W (2024) Filling the data gap on CGRP mAb therapy in low- to middle-income countries in Southeast asia: insights from a real-world study in Thailand. J Headache Pain 25(1):150","journal-title":"J Headache Pain"},{"issue":"1","key":"2295_CR57","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.vhri.2013.03.001","volume":"2","author":"R Daems","year":"2013","unstructured":"Daems R, Maes E, Glaetzer C (2013) Equity in pharmaceutical pricing and reimbursement: crossing the income divide in Asia Pacific. Value Health Reg Issues 2(1):160\u2013166","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"2295_CR58","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s10194-023-01594-1","volume":"24","author":"C Lampl","year":"2023","unstructured":"Lampl C, MaassenVanDenBrink A, Deligianni CI, Gil-Gouveia R, Jassal T, Sanchez-Del-Rio M et al (2023) The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis. J Headache Pain 24(1):56","journal-title":"J Headache Pain"},{"issue":"1","key":"2295_CR59","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s10194-025-02074-4","volume":"26","author":"P Anukoolwittaya","year":"2025","unstructured":"Anukoolwittaya P, Rattanawong W, Vongvaivanich K, Pongpitakmetha T, Thanprasertsuk S, Poonpedpun T et al (2025) Expert consensus on gepants for acute and preventive treatment of migraine in Thailand. J Headache Pain 26(1):131","journal-title":"J Headache Pain"},{"key":"2295_CR60","doi-asserted-by":"publisher","first-page":"100466","DOI":"10.1016\/j.ensci.2023.100466","volume":"31","author":"R Gouider","year":"2023","unstructured":"Gouider R, Lorenz DH, Craven A, Grisold W, Dodick DW (2023) Advocacy for patients with headache disorders. eNeurologicalSci 31:100466","journal-title":"eNeurologicalSci"}],"updated-by":[{"DOI":"10.1186\/s10194-026-02317-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000}}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-026-02295-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02295-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02295-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:02:52Z","timestamp":1772618572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10194-026-02295-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2295"],"URL":"https:\/\/doi.org\/10.1186\/s10194-026-02295-1","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s10194-026-02317-y","URL":"https:\/\/doi.org\/10.1186\/s10194-026-02317-y","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles outlined in the Declaration of Helsinki and the International Conference on Harmonisation\u2013Good Clinical Practice (ICH-GCP). Ethical approval was obtained from the Institutional Review Board of King Mongkut\u2019s Institute of Technology Ladkrabang, Bangkok, Thailand (EC-KMITL_67_132), and local ethics approvals were secured in participating countries where applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SH, WS, AH and AS report no significant conflict of interest related to this topic. PA has received speaker and advisory board honoraria from BL HUA, DKSH, Lundbeck, Pfizer, and ZP Therapeutics. TP has received speaker honoraria from BL HUA, Daiichi Sankyo, Eisai, Lundbeck, Pfizer, Servier, and ZP Therapeutics. ST reports speaker and advisory board honoraria from BL HUA, DKSH, Lundbeck, Pfizer, Viatris, and ZP Therapeutics. WR declares receiving speaker and advisory board honoraria from BL HUA, DKSH, Lundbeck, Pfizer, Viatris, and ZP Therapeutics. SJT reports research funding from Abbvie, Aeon, Amgen, Annovis, Axsome, Biohaven, Bristol Myer Squibb, Cassava, Cognition, Eli Lilly, Inhibikase, Ipsen, Johnson and Johnson\/Intracellular, Karuna, Lundbeck, Merz, Neurocrine, Neurolief, Pfizer, PrecisionMed, Revance, Satsuma, Scilex, Suven, UCB, and Upsher Smith; Consuling and\/or Advisory Boards (honoraria) from Abbvie, Aeon, Alphasights, Amgen, Aruene\/eNeura, Atheneum, Axsome Therapeutics, Bausch Health, Becker Pharmaceutical Consulting, Biohaven, Catch Therapeutics, ClearView Healthcare Partners, ClickTherapeutics, CoolTech, CRG, Decision Resources, Defined Health, DRG, DocDelta, Dr. Reddy\u2019s, Eli Lilly, ExpertConnect, FCB Health, Fenix, Gilmartin Capital, GLG, Guidepoint Global, Health Advances, Health Science Communications, HMP Communications, Impel, Initiator Pharma, InteractiveForums, IQVIA, Keyquest, KLJ Associates, Krog and Partners, Lundbeck, M3 Global Research, Magellan Health, Magnolia Innovation, Miravo Healthcare, MJH Holdings, Neurofront Therapeutics, Neurolief, Nocira, Novartis, P Value Communications, Pain Insights, Inc, Palion Medical, Paragon Therapeutics, Perfood, Pfizer, Pulmatrix, Putnam Associates, Rehaler, SAI MedPartners, Satsuma, Scilex, Slingshot Insights, Spherix Global Insights, Strategy Inc, Synapse Medical Communication, System Analytic, Taylor and Francis, Tegus, Teva, Theranica, Third Bridge, Tonix, Trinity Partners, Unity HA, Vial, and XOC; salary from the Thomas Jefferson University and Ki Health Partners, Speakers Bureau for AbbVie, Amneal, Axsome, Dr. Reddy\u2019s, Eli Lilly, Lundbeck, Pfizer, Scilex, Teva, and Tonix; CME honoraria from American Academy of Neurology, American Headache Society, Annenberg Center for Health Sciences, Catamount Medical Education, Consortium for Research Education Social Awareness and Training In Neurosciences, Diamond Education Foundation, Forefront Collaborative, Haymarket Medical Education, HMP Global, Medical Education Speakers Network, Medical Learning Institute Peerview, Migraine Association of Ireland, Miller Medical Education, National Association for Continuing Education, North American Center for CME, The Ohio State University, Physicians\u2019 Education Resource, PlatformQ Education, Primed, Vindico Medical Education, and WebMD\/Medscape; travel support from AbbVie, American Headache Society, Amneal, Diamond Headache Clinic, Dr. Reddy\u2019s, Eli Lilly, Lundbeck, and Pfizer, and book royalties from Springer Health.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}